Wolff Wiese Magana’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Hold
141
0.01% 453
2026
Q1
$11.3K Hold
141
0.01% 441
2025
Q4
$12K Buy
141
+38
+37% +$3.12K 0.01% 411
2025
Q3
$8.01K Hold
103
﹤0.01% 493
2025
Q2
$8.06K Hold
103
0.01% 463
2025
Q1
$7.47K Buy
103
+33
+47% +$2.36K 0.01% 464
2024
Q4
$5.18K Buy
70
+20
+40% +$1.4K ﹤0.01% 549
2024
Q3
$3.3K Sell
50
-10
-17% -$727 ﹤0.01% 652
2024
Q2
$5.54K Buy
60
+10
+20% +$886 ﹤0.01% 414
2024
Q1
$4.78K Hold
50
﹤0.01% 400
2023
Q4
$3.81K Sell
50
-15
-23% -$1.04K ﹤0.01% 409
2023
Q3
$4.5K Buy
65
+5
+8% +$402 ﹤0.01% 449
2023
Q2
$5.66K Hold
60
﹤0.01% 428
2023
Q1
$4.96K Hold
60
﹤0.01% 428
2022
Q4
$4.48K Buy
60
+10
+20% +$771 ﹤0.01% 426
2022
Q3
$4K Sell
50
-15
-23% -$1.44K ﹤0.01% 636
2022
Q2
$6K Buy
65
+15
+30% +$1.55K ﹤0.01% 606
2022
Q1
$6K Hold
50
﹤0.01% 605
2021
Q4
$6K Hold
50
﹤0.01% 605
2021
Q3
$6K Buy
50
+32
+178% +$3.65K ﹤0.01% 597
2021
Q2
$2K Buy
+18
New +$1.7K ﹤0.01% 712

Other funds holding EW

Wolff Wiese Magana's EW Position: Q2 2026 in Review

Wolff Wiese Magana held its Edwards Lifesciences (EW) position steady in Q2 2026 at 141 shares worth $12.8K. The position accounts for 0.01% of the portfolio, ranked #453.

Wolff Wiese Magana first reported a position in EW in Q2 2021 and has held it in 21 quarters since. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Wolff Wiese Magana held 141 shares of Edwards Lifesciences worth $12.8K as of Q2 2026.
  • Wolff Wiese Magana left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #453 holding.
  • Wolff Wiese Magana first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.